JP2020502545A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502545A5 JP2020502545A5 JP2019553597A JP2019553597A JP2020502545A5 JP 2020502545 A5 JP2020502545 A5 JP 2020502545A5 JP 2019553597 A JP2019553597 A JP 2019553597A JP 2019553597 A JP2019553597 A JP 2019553597A JP 2020502545 A5 JP2020502545 A5 JP 2020502545A5
- Authority
- JP
- Japan
- Prior art keywords
- proteins
- level
- red blood
- blood cell
- blood sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023005614A JP7425903B2 (ja) | 2016-12-20 | 2023-01-18 | プロテアーゼインヒビターを用いる血液プロファイリング |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662436875P | 2016-12-20 | 2016-12-20 | |
| US62/436,875 | 2016-12-20 | ||
| US201762482582P | 2017-04-06 | 2017-04-06 | |
| US62/482,582 | 2017-04-06 | ||
| US201762523489P | 2017-06-22 | 2017-06-22 | |
| US62/523,489 | 2017-06-22 | ||
| PCT/AU2017/000282 WO2018112500A1 (en) | 2016-12-20 | 2017-12-18 | Blood profiling with protease inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023005614A Division JP7425903B2 (ja) | 2016-12-20 | 2023-01-18 | プロテアーゼインヒビターを用いる血液プロファイリング |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020502545A JP2020502545A (ja) | 2020-01-23 |
| JP2020502545A5 true JP2020502545A5 (enExample) | 2021-02-18 |
Family
ID=62624059
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019553597A Pending JP2020502545A (ja) | 2016-12-20 | 2017-12-18 | プロテアーゼインヒビターを用いる血液プロファイリング |
| JP2023005614A Active JP7425903B2 (ja) | 2016-12-20 | 2023-01-18 | プロテアーゼインヒビターを用いる血液プロファイリング |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023005614A Active JP7425903B2 (ja) | 2016-12-20 | 2023-01-18 | プロテアーゼインヒビターを用いる血液プロファイリング |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11693006B2 (enExample) |
| EP (1) | EP3559253A4 (enExample) |
| JP (2) | JP2020502545A (enExample) |
| CN (1) | CN110366597B (enExample) |
| AU (1) | AU2017379367B2 (enExample) |
| CA (1) | CA3047607A1 (enExample) |
| WO (1) | WO2018112500A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108700565B (zh) | 2015-10-07 | 2021-10-29 | 善威生物私人有限公司 | 血液制备和图谱分析 |
| CA3009369A1 (en) | 2015-12-22 | 2017-06-29 | Sangui Bio Pty. Ltd | Therapeutic methods using erythrocytes |
| WO2018112500A1 (en) | 2016-12-20 | 2018-06-28 | Sangui Bio Pty. Ltd | Blood profiling with protease inhibitors |
| CN111999503B (zh) * | 2020-05-28 | 2022-05-20 | 首都医科大学附属北京地坛医院 | 一组用于预测急性病毒性呼吸道传染病重症化的标志物及其应用和试剂盒 |
| US11905249B2 (en) | 2021-01-25 | 2024-02-20 | Jackson State University | Covalent inhibitors of equine encephalitis virus |
| US20230358759A1 (en) * | 2022-05-04 | 2023-11-09 | Creative Medical Technologies, Inc. | Cytokine based assessment of recipient ability to respond to stem cell therapy for cartilage regeneration |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4931276A (en) | 1987-10-30 | 1990-06-05 | Franco Robert S | Method for introducing desired agents into red blood cells |
| US5858358A (en) | 1992-04-07 | 1999-01-12 | The United States Of America As Represented By The Secretary Of The Navy | Methods for selectively stimulating proliferation of T cells |
| WO1992005801A1 (en) | 1990-10-04 | 1992-04-16 | University Of Virginia Alumni Patents Foundation | Primate erythrocyte bound monoclonal antibody heteropolymers |
| FR2778851B1 (fr) | 1998-05-19 | 2002-07-26 | Aetsrn | Composition a base d'inhibiteurs de cysteine-proteases pour retarder la senescence, l'autodestruction et l'hemolyse des erythrocytes |
| US8431117B2 (en) | 1999-08-30 | 2013-04-30 | David S Terman | Sickled erythrocytes with anti-tumor agents induce tumor vaso-occlusion and tumoricidal effects |
| AU2001272670A1 (en) | 2000-07-24 | 2002-02-05 | Gendel Limited | Polypeptide delivery II-2 |
| PT1495328E (pt) | 2002-04-16 | 2014-09-09 | Vlaams Interuniv Inst Biotech | Um marcador para medir cirrose hepática |
| US7191068B2 (en) | 2003-03-25 | 2007-03-13 | Proteogenix, Inc. | Proteomic analysis of biological fluids |
| GB0325483D0 (en) | 2003-10-31 | 2003-12-03 | Plasmacute As | Assay |
| AU2004286307A1 (en) * | 2003-10-31 | 2005-05-12 | Vitatex, Inc. | Blood test prototypes and methods for the detection of circulating tumor and endothelial cells |
| US20080095749A1 (en) | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
| US7378054B2 (en) | 2004-04-16 | 2008-05-27 | Savvipharm Inc | Specimen collecting, processing and analytical assembly |
| ATE519109T1 (de) * | 2004-12-21 | 2011-08-15 | Univ Yale | Präeklampsie-diagnose |
| US20060166223A1 (en) | 2005-01-26 | 2006-07-27 | Reed Michael W | DNA purification and analysis on nanoengineered surfaces |
| WO2006123253A2 (en) * | 2005-03-29 | 2006-11-23 | Inverness Medical Switzerland Gmbh | Device and method of monitoring a patient |
| US20100184049A1 (en) | 2007-04-27 | 2010-07-22 | Steve Goodison | Glycoprotein Profiling of Bladder Cancer |
| FR2919804B1 (fr) | 2007-08-08 | 2010-08-27 | Erytech Pharma | Composition et vaccin therapeutique anti-tumoral |
| US20110245092A1 (en) | 2008-03-04 | 2011-10-06 | John Bilello | Diagnosing and monitoring depression disorders based on multiple serum biomarker panels |
| KR20210003301A (ko) | 2008-05-06 | 2021-01-11 | 아스텔라스 인스티튜트 포 리제너러티브 메디슨 | 다능성 줄기세포로부터 유도된 탈핵 적혈구계 세포를 생산하는 방법 |
| EP2442641A4 (en) | 2009-06-16 | 2016-03-09 | Univ Columbia | METHOD FOR REDUCING SIDE EFFECTS OF THE TRANSFUSION OF AGED RED BLOOD CELLS |
| EP2464966A1 (en) | 2009-08-13 | 2012-06-20 | Basf Se | Means and methods for diagnosingthyroid disorders |
| US20130202625A1 (en) | 2010-01-21 | 2013-08-08 | The Regents Of The University Of Californa | Use of human erythrocytes for prevention and treatment of cancer dissemination and growth |
| WO2011127056A2 (en) * | 2010-04-05 | 2011-10-13 | The Uab Research Foundation | Biomarkers for assessing exposure to ionizing radiation and absorbed dose |
| SG195180A1 (en) | 2011-05-31 | 2013-12-30 | Singapore Health Serv Pte Ltd | Method for detecting disease biomarkers |
| DK2730650T3 (en) | 2011-07-06 | 2017-04-10 | Histocell Sl | Method of Treating Mesenchymal Stem Cells and Their Use in Treating Oxidative Stress Diseases |
| GB201116767D0 (en) | 2011-09-28 | 2011-11-09 | St George S Hospital Medical School | Treatment for mitrochondrial neurogastrointestinal encephalomyopathy |
| CN104394884A (zh) | 2012-03-21 | 2015-03-04 | 爱瑞泰克药物公司 | 用于治疗急性髓细胞白血病(aml)的药剂 |
| HU230341B1 (hu) | 2012-04-20 | 2016-02-29 | Advancell Diagnosztika Kft. | A vörösvérsejt-membrán kvantitatív biomarkerei |
| EP2872154B1 (en) | 2012-07-11 | 2017-05-31 | Sangamo BioSciences, Inc. | Methods and compositions for delivery of biologics |
| EP2994117B1 (en) | 2013-05-10 | 2023-06-07 | EryDel S.p.A. | Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes |
| JP6383920B2 (ja) | 2013-09-11 | 2018-09-05 | 有限会社ピコデバイス | パーキンソン病の判定基準とする方法 |
| KR101845588B1 (ko) | 2014-04-07 | 2018-04-05 | 한양대학교 산학협력단 | 적혈구계 세포의 인 비트로 확장 |
| BR122021024421B1 (pt) | 2015-05-18 | 2022-05-03 | Hemanext Inc | Usos de um produto de sangue total armazenado reduzido de oxigênio com plaquetas |
| CN108700565B (zh) | 2015-10-07 | 2021-10-29 | 善威生物私人有限公司 | 血液制备和图谱分析 |
| CA3009369A1 (en) | 2015-12-22 | 2017-06-29 | Sangui Bio Pty. Ltd | Therapeutic methods using erythrocytes |
| WO2018112500A1 (en) | 2016-12-20 | 2018-06-28 | Sangui Bio Pty. Ltd | Blood profiling with protease inhibitors |
-
2017
- 2017-12-18 WO PCT/AU2017/000282 patent/WO2018112500A1/en not_active Ceased
- 2017-12-18 EP EP17882505.5A patent/EP3559253A4/en active Pending
- 2017-12-18 AU AU2017379367A patent/AU2017379367B2/en active Active
- 2017-12-18 US US16/471,479 patent/US11693006B2/en active Active
- 2017-12-18 CA CA3047607A patent/CA3047607A1/en active Pending
- 2017-12-18 CN CN201780087011.XA patent/CN110366597B/zh active Active
- 2017-12-18 JP JP2019553597A patent/JP2020502545A/ja active Pending
-
2023
- 2023-01-18 JP JP2023005614A patent/JP7425903B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Koelman et al. | Cytokines for evaluation of chronic inflammatory status in ageing research: reliability and phenotypic characterisation | |
| Liu et al. | Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review | |
| Nogueira et al. | Diagnostic biomarkers for active tuberculosis: progress and challenges | |
| Wassall et al. | Clinical and technical considerations in the analysis of gingival crevicular fluid | |
| Yetley et al. | Biomarkers of vitamin B-12 status in NHANES: a roundtable summary | |
| Wood et al. | Validation of cell‐based fluorescence assays: practice guidelines from the ICSH and ICCS–part V–assay performance criteria | |
| Sheldon et al. | C-reactive protein and its cytokine mediators in intensive-care patients | |
| Thyagarajan et al. | Analytical and biological variability in biomarker measurement in the Hispanic Community Health Study/Study of Latinos | |
| Cray et al. | Assessement of serum amyloid A levels in the rehabilitation setting in the Florida manatee (Trichechus manatus latirostris) | |
| CY1107859T1 (el) | Μεθοδος για διαγνωση πολλαπλης σκληρυνσης | |
| US12515222B2 (en) | Diagnostic system for hemoglobin analysis | |
| WO2007032788A3 (en) | Method and apparatus for gel electrophoretic immunoassay | |
| RU2009142935A (ru) | Маркеры заболевания | |
| RU2019143570A (ru) | Диагностика периодонтита на основании hgf и mmp-8 в слюне | |
| De Graaf et al. | Nickel allergy is associated with a broad spectrum cytokine response | |
| JP2018530766A5 (enExample) | ||
| Ravindran et al. | Exploratory study on plasma immunomodulator and antibody profiles in tuberculosis patients | |
| Dittadi et al. | Two SARS-CoV-2 IgG immunoassays comparison and time-course profile of antibodies response | |
| Plickert et al. | Evaluation of a point‐of‐care test for canine C‐reactive protein | |
| Jenkinson et al. | Biochemical analysis of pleural and ascitic fluid: effect of sample timing on interpretation of results | |
| KR101349054B1 (ko) | 마이크로 칩을 포함하는 바이오 센서장치 | |
| Najjar et al. | Application of serum C-reactive protein in comparison with βeta-2-microglobulin in patient with multiple myeloma | |
| Dinesan et al. | Evaluation of Salivary 8-Isoprostane in oral lichen planus: Case control study | |
| RU2019143602A (ru) | Диагностика гингивита на основании ил-1бета и фактора роста гепатоцитов в слюне | |
| Chaurasia et al. | A comparison of glomerular filtration rate by creatinine based equations and DTPA-renogram in healthy adult kidney donors. |